The Discovery of TRPV1 Antagonists: Turning up the Heat - Accounts in Drug Discovery Case Studies in Medicinal Chemistry - page 313

39. R. J. Docherty, J. C. Yeats and A. S. Piper, Br. J. Pharmacol., 1997, 121,
1461.
40. L. Liu and S. A. Simon, Neurosci. Lett., 1997, 228,29.
41. M. J. Caterina, A. Leer, A. B. Malmberg, W. J. Martin, J. Trafton, K. R.
Petersen-Zeitz, M. Koltzenburg, A. I. Basbaum and D. Julius, Science,
2000, 288, 306.
42. J. B. Davis, J. Gray, M. J. Gunthrope, J. P. Hatcher, P. T. Davey,
P. Overend, M. H. Harries, J. Latcham, C. Clapham, K. Atkinson, S. A.
Hughes, K. Rance, E. Grau, A. J. Harper, P. L. Pugh, D. C. Rogers,
S. Bingham, A. Randall and S. A. Sheardown, Nature, 2000, 405, 183.
43. G. Appendino, E. Munoz and B. L. Fiebich, Exp. Opin. Ther. Pat., 2003,
13, 1825.
44. Introduction from J. Med. Chem., 2007, 50, 3497; adapted with permission.
45. N. R. Gavva, R. Tamir, Y. Qu, L. Klionsky, T. J. Zhang, D. Immke,
J. Wang, D. Zhu, T. W. Vanderah, F. Porreca, E. M. Doherty, M. H.
Norman, K. D. Wild, A. W. Bannon, J. C. Louis and J. J. S. Treanor,
J. Pharmacol. Exp. Ther., 2005, 313, 474.
46. V. I. Ognyanov, C. Balan, A. W. Bannon, Y. Bo, C. Dominguez,
C. Fotsch, V. K. Gore, L. Klionsky, V. M. Ma, Y. X. Qian, R. Tamir,
X. Wang, N. Xi, S. Xu, D. Zhu, N. R. Gavva, J. J. S. Treanor and M. H.
Norman, J. Med. Chem., 2006, 49, 3719.
47. N. Xi, Y. Bo, E. M. Doherty, C. Fotsch, N. Gavva, N. Han, R. W.
Hungate, L. Klionsky, Q. Liu, R. Tamir, S. Xu, J. J. S. Treanor and M. H.
Norman, Bioorg. Med. Chem. Lett., 2005, 15, 5211.
48. V. K. Gore, V. V. Ma, R. Tamir, N. R. Gavva, J. J. S. Treanor and M. H.
Norman, Bioorg. Med. Chem. Lett., 2007, 17, 5825.
49. E. M. Doherty, C. Fotsch, Y. Bo, P. Chakrabarti, N. Chen, N. R. Gavva,
N. Han, M. G. Kelly, J. Kincaid, L. Klionsky, Q. Liu, V. I. Ognyanov,
R. Tamir, Q. Wang, Z. Zhu, M. H. Norman and J. J. S. Treanor, J. Med.
Chem., 2005, 48,71.
50. Human and rat liver microsome incubation studies reported herein were
conducted in a 1M phosphate pH7.4 buffer for a 10-min period with a final
liver microsome concentration of 0.1mgmL 1 , a final compound con-
centration of 1 mM, and a final NADPH concentration of 1 mM. Under
these conditions, a cut off of o 100 mLmin -1 mg 1 was considered

desirable.
51. J. Zhu, V. N. Viswanadhan, V. I. Ognyanov, Y. Bo, N. Chen, P. Chakrabarti,
E. M. Doherty, C. Fotsch, N. R. Gavva, N. Han, L. Klionski, Q. Liu,
R.Tamir,X.Wang,Y.Sun,J.J.S.TreanorandM.H.Norman,presentedat
the 229th ACS National Meeting, San Diego, March 2005, abstr. MEDI-101.
52. V. N. Viswanadhan, Y. Sun and M. H. Norman, J. Med. Chem., 2007, 500,
5608.
53. D. B. Boyd, Reviews in Computational Chemistry, ed. K. B. Lipkowitz and
D. B. Boyd, VCH, Weinheim, 1990, vol. 1, p. 321.
54. M. H. Norman, J. Zhu, C. Fotsch, Y. Bo, N. Chen, P. Chakrabarti, E. M.
Doherty, N. R. Gavva, N. Nishimura, T. Nixey, V. I. Ognyanov, R. M.